NCDs Impose 1.6 Trillion Baht Economic Burden on Thailand
The Pharmaceutical Research and Manufacturers Association (PReMA) reports that non-communicable diseases cost Thailand 1.6 trillion baht annually, urging earlier screening for hypertension and diabetes.
According to a report by Prachachat Business, the Pharmaceutical Research and Manufacturers Association (PReMA) has highlighted the significant economic impact of non-communicable diseases (NCDs) in Thailand. The association estimates that these chronic conditions result in an annual economic burden of 1.6 trillion baht, which accounts for approximately 9.7% of the nation's GDP. This figure reflects losses in productivity and challenges related to the early diagnosis of hypertension and diabetes.
PReMA advocates for a more holistic approach to managing these health issues, emphasizing the importance of early screening and intervention. For residents and long-term visitors, this report underscores the prevalence of chronic health conditions within the local population and the ongoing efforts by health organizations to improve diagnostic accessibility. While the economic data provides a clear picture of the systemic strain caused by NCDs, the specific policy changes or government-led initiatives that may follow this proposal remain to be confirmed. Travelers are encouraged to ensure they have adequate health insurance coverage, as managing chronic conditions can be complex. The report serves as a reminder of the importance of proactive health management while residing in or visiting the country.
